Ferroptosis in neurological diseases: moving towards therapeutic intervention
Molecular Psychiatry · 2026-06 · 31 (6) · 3108-3126
DOI: 10.1038/s41380-026-03445-2 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular Psychiatry, online erschienen am 19.01.2026. Verfasst von Qing-Zhang Tuo und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geriatrics and State Key Laboratory of Biotherapy, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan Unive…. Hauptthemen laut MEDLINE: Ferroptosis, Nervous System Diseases. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 276 Literaturangaben.
Abstract (Originalsprache)
Ferroptosis is a regulated cell death driven by iron-dependent lipid peroxidation and has been implicated in major neurological diseases. The brain is enriched in polyunsaturated fatty acids (PUFAs) and iron, which makes it particularly susceptible to lipid peroxidation, leading to ferroptosis. In neurological diseases such as Alzheimer's disease (AD) and stroke, such mechanisms are dysregulated and contribute to neuronal loss. Physiologically, the lipid peroxidation resistance systems in the brain, including defenses (such as SOD, CAT, Prxs, GPxs) and repair systems (such as GPx4, FSP1), prevent ferroptosis and repair damaged phospholipid membranes. However, the efficacy of endogenous resistance systems is often compromised in pathological states, positioning exogenous antioxidants as promising therapeutic candidates. Future research could optimize the delivery of these compounds and explore new candidates that specifically target the ferroptosis signaling pathway to prevent neurodegeneration occurring in neurological diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Geriatrics and State Key Laboratory of Biotherapy, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China.
- Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Victoria, 3052, Australia. ashley.bush@florey.edu.au.
- Department of Geriatrics and State Key Laboratory of Biotherapy, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China. peng.lei@scu.edu.cn.
- Department of Neurology and State Key Laboratory of Biotherapy, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China. peng.lei@scu.edu.cn.
ORCID-Profile: Ashley I Bush, Peng Lei
Zitieren
APA
Tuo, Q. Z., Bush, A. I., & Lei, P. (2026). Ferroptosis in neurological diseases: moving towards therapeutic intervention. Molecular Psychiatry, 31(6), 3108-3126. https://doi.org/10.1038/s41380-026-03445-2
Vancouver
Tuo QZ, Bush AI, Lei P. Ferroptosis in neurological diseases: moving towards therapeutic intervention. Molecular Psychiatry. 2026;31(6):3108-3126. doi:10.1038/s41380-026-03445-2
BibTeX
@article{Tuo2026,
author = {Tuo, Qing-Zhang and Bush, Ashley I and Lei, Peng},
title = {Ferroptosis in neurological diseases: moving towards therapeutic intervention},
journal = {Molecular Psychiatry},
year = {2026},
volume = {31},
number = {6},
pages = {3108--3126},
doi = {10.1038/s41380-026-03445-2}
}
EUVIMED